A novel monoclonal antibody with improved FcγR blocking ability demonstrated non-inferior efficacy compared to IVIG in cynomolgus monkey ITP model at considerably lower dose

por Nakajima-Kato, Yuko, Komai, Masato, Yoshida, Tadashi, Kanai, Akiko
Publicado 2022

The Pursuit of the “Inside” of the Amyloid Hypothesis—Is C99 a Promising Therapeutic Target for Alzheimer’s Disease?

por Takasugi, Nobumasa, Komai, Masato, Kaneshiro, Nanaka, Ikeda, Atsuya, Kamikubo, Yuji, Uehara, Takashi
Publicado 2023

Lipid flippase dysfunction as a therapeutic target for endosomal anomalies in Alzheimer’s disease

por Kaneshiro, Nanaka, Komai, Masato, Imaoka, Ryosuke, Ikeda, Atsuya, Kamikubo, Yuji, Saito, Takashi, Saido, Takaomi C., Tomita, Taisuke, Hashimoto, Tadafumi, Iwatsubo, Takeshi, Sakurai, Takashi, Uehara, Takashi, Takasugi, Nobumasa
Publicado 2022